IonQ (IONQ) valuation

Computer Hardware · NYSE · Information Technology

$24.84 -6.09% Close Nov 17, 2026 Live

TrendArc score 28 of 100 · Health 2.2 · Momentum 0.1 · Moat 4.4 · scored Nov 17, 2026 · How the score works

IonQ P/E ratio history

As of November 17, 2026, IonQ trades at 26.4 times its earnings over the last twelve months.

At each fiscal year end. Price is our close on that day; EPS is the fiscal year's diluted earnings per share, both in today's shares.
Fiscal year endedPriceEPSP/E
Dec 31, 2025$44.87-$1.82n/m
Dec 31, 2024$41.77-$1.56n/m
Dec 31, 2023$12.39-$0.78n/m
Dec 31, 2022$3.45-$0.25n/m
Dec 31, 2021$16.70-$0.76n/m

n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.

IonQ valuation against its peers

At the close on Nov 17, 2026.
CompanyMarket valueP/EForward P/EPrice / sales
IonQIONQ $9.46B 26.4—24.9
NovaNVMI $9.81B 35.323.59.8
Skyworks SolutionsSWKS $12.9B 75.415.03.3
First SolarFSLR $16.4B 8.97.03.3
CamtekCAMT $4.43B 35.820.08.1
Credo TechnologyCRDO $23.1B 43.617.314.5
Qnity ElectronicsQ $24.0B 43.219.94.4
Cerebras SystemsCBRS $24.7B ———
ON SemiconductorON $26.4B 40.715.54.2
Peer median40.717.34.4

Reading these multiples

The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.

See also: IONQ financials · IONQ returns

No forecast, no recommendation. This page describes IonQ from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Nov 17, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.

The TrendArc score, from 0 to 100, combines three pillars measured from published data, Health (business quality over the last twelve months), Momentum (the price against its moving averages, its 52-week high and the market) and Moat (durability over five years), with the share price's long-run trend. It describes the company as it stands today. It is not a forecast or a recommendation.